Japan Conjugate Vaccine Market by Disease Indication and End-User – Forecast to 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Japan Conjugate Vaccine Market (2018-2023)” report has been added to ResearchAndMarkets.com’s offering. Japan is one of the most prominent markets of conjugate vaccines. …
( read original story …)


Related Post

Japan’s Abe heads to Washington this week bearing ...
views 236
Japan’s prime minister, a man who promised voters ...
Japan approves missile defence system amid North K...
views 210
TOKYO — Japan’s Cabinet on Tuesday approved a plan...
Japan’s new symbols for high-tech toilets get offi...
views 242
Toilet makers in Japan last year teamed up to flus...
R3 blockchain consortium welcomes Japanese banking...
views 171
SBI Bank, a Russian commercial banking subsidiary ...
A few Bank of Japan members called for more focus ...
views 45
TOKYO (Reuters) - A few Bank of Japan board member...
Adtech company AdAsia Holdings raises US$12M, has ...
views 279
AdAsia has been planning to IPO from day one, and ...
WRC set to shelve Rally Japan plan from 2019 calen...
views 33
Earlier this year, managing director of WRC Promot...
Budget cuts threaten rollout of earthquake early w...
views 236
Now, those plans, and the lives it could save, cou...
Shohei Ohtani bids farewell to Japanese fans ahead...
views 175
SAPPORO, Japan (AP) — Los Angeles Angels-bound Sho...
Tokyo DisneySea Theme Park Set for $2.3 Billion Up...
views 72
Tokyo DisneySea, the theme park located next door ...